Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2008 (2008), Article ID 407972, 9 pages
http://dx.doi.org/10.1155/2008/407972
Clinical Study

Homocysteine May Involve in the Pathogenesis of Behcet's Disease by Inducing Inflammation

1Department of Dermatology, Diskapi Yildirim Beyazit Education and Research Hospital, Ministry of Health Ankara, 06110 Ankara, Turkey
2Department of Cardiovascular Surgery, Turkiye Yuksek Ihtisas Education and Research Hospital, Ministry of Health Ankara, 06100 Ankara, Turkey

Received 1 August 2008; Revised 2 November 2008; Accepted 17 November 2008

Academic Editor: Dennis Daniel Taub

Copyright © 2008 Selda Pelin Kartal Durmazlar et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. S. McCully, “Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis,” American Journal of Pathology, vol. 56, no. 1, pp. 111–128, 1969. View at Google Scholar
  2. L. A. Harker, S. J. Slichter, C. R. Scott, and R. Ross, “Homocystinemia. Vascular injury and arterial thrombosis,” The New England Journal of Medicine, vol. 291, no. 11, pp. 537–543, 1974. View at Google Scholar
  3. L. A. Harker, J. M. Harlan, and R. Ross, “Effect of sulfinpyrazone on homocysteine-induced endothelial injury and arteriosclerosis in baboons,” Circulation Research, vol. 53, no. 6, pp. 731–739, 1983. View at Google Scholar
  4. M. Hansrani, J. I. Gillespie, and G. Stansby, “Homocysteine in myointimal hyperplasia,” European Journal of Vascular and Endovascular Surgery, vol. 23, no. 1, pp. 3–10, 2002. View at Publisher · View at Google Scholar · View at PubMed
  5. M. Den Heijer, F. R. Rosendaal, H. J. Blom, W. B. J. Gerrits, and G. M. J. Bos, “Hyperhomocysteinemia and venous thrombosis: a meta-analysis,” Thrombosis and Haemostasis, vol. 80, no. 6, pp. 874–877, 1998. View at Google Scholar
  6. J. G. Ray, “Meta-analysis of hyperhomocysteinemia as a risk factor for venous thromboembolic disease,” Archives of Internal Medicine, vol. 158, no. 19, pp. 2101–2106, 1998. View at Publisher · View at Google Scholar
  7. D. S. Wald, M. Law, and J. K. Morris, “Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis,” British Medical Journal, vol. 325, no. 7374, pp. 1202–1206, 2002. View at Publisher · View at Google Scholar
  8. R. Clarke, R. Collins, S. Lewington et al., “Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis,” The Journal of the American Medical Association, vol. 288, no. 16, pp. 2015–2022, 2002. View at Publisher · View at Google Scholar
  9. P. Durand, M. Prost, N. Loreau, S. Lussier-Cacan, and D. Blache, “Impaired homocysteine metabolism and atherothrombotic disease,” Laboratory Investigation, vol. 81, no. 5, pp. 645–672, 2001. View at Google Scholar
  10. G. J. Hankey and J. W. Eikelboom, “Homocysteine and vascular disease,” The Lancet, vol. 354, no. 9176, pp. 407–413, 1999. View at Publisher · View at Google Scholar
  11. H. Behcet, “Über rezidivierende, aphtöse, durch ein virus verursachte Geshwüre am Mund am Auge und an den Genitalien,” Dermatol Wochensch, vol. 105, pp. 1152–1157, 1937. View at Google Scholar
  12. Y. Koc, I. Güllü, G. Akpek et al., “Vascular involvement in Behçet's disease,” Journal of Rheumatology, vol. 19, no. 3, pp. 402–410, 1992. View at Google Scholar
  13. N. P. B. Dudman, S. E. Temple, X. W. Guo, W. Fu, and M. A. Perry, “Homocysteine enhances neutrophil-endothelial interactions in both cultured human cells and rats in vivo,” Circulation Research, vol. 84, no. 4, pp. 409–416, 1999. View at Google Scholar
  14. K. Aksu, N. Turgan, F. Oksel et al., “Hyperhomocysteinaemia in Behçet's disease,” Rheumatology, vol. 40, no. 6, pp. 687–690, 2001. View at Publisher · View at Google Scholar
  15. H. Er, C. Evereklioglu, T. Cumurcu et al., “Serum homocysteine level is increased and correlated with endothelin-1 and nitric oxide in Behçet's disease,” British Journal of Ophthalmology, vol. 86, no. 6, pp. 653–657, 2002. View at Publisher · View at Google Scholar
  16. A. Ateş, O. Aydıntuǧ, U. Ölmez, N. Düzgün, and M. Duman, “Serum homocysteine level is higher in Behçet's disease with vascular involvement,” Rheumatology International, vol. 25, no. 1, pp. 42–44, 2005. View at Publisher · View at Google Scholar · View at PubMed
  17. T. Sarican, H. Ayabakan, S. Turkmen, V. Kalaslioglu, F. Baran, and N. Yenice, “Homocysteine: an activity marker in Behçet's disease?,” Journal of Dermatological Science, vol. 45, no. 2, pp. 121–126, 2007. View at Publisher · View at Google Scholar · View at PubMed
  18. Y. Özkan, S. Yardım-Akaydın, A. Sepici, B. Engin, V. Sepici, and B. Şimşek, “Assessment of homocysteine, neopterin and nitric oxide levels in Behçet's disease,” Clinical Chemistry and Laboratory Medicine, vol. 45, no. 1, pp. 73–77, 2007. View at Publisher · View at Google Scholar · View at PubMed
  19. Z. Yesilova, S. Pay, C. Oktenli et al., “Hyperhomocysteinemia in patients with Behçet's disease: is it due to inflammation or therapy?,” Rheumatology International, vol. 25, no. 6, pp. 423–428, 2005. View at Publisher · View at Google Scholar · View at PubMed
  20. R. Ozdemir, I. Barutcu, A. T. Sezgin et al., “Vascular endothelial function and plasma homocysteine levels in Behçet's disease,” The American Journal of Cardiology, vol. 94, no. 4, pp. 522–525, 2004. View at Publisher · View at Google Scholar · View at PubMed
  21. Y. J. Lee, S. W. Kang, J. I. Yang et al., “Coagulation parameters and plasma total homocysteine levels in Behçet's disease,” Thrombosis Research, vol. 106, no. 1, pp. 19–24, 2002. View at Publisher · View at Google Scholar
  22. M. Leiba, U. Seligsohn, Y. Sidi et al., “Thrombophilic factors are not the leading cause of thrombosis in Behçet's disease,” Annals of the Rheumatic Diseases, vol. 63, no. 11, pp. 1445–1449, 2004. View at Publisher · View at Google Scholar · View at PubMed
  23. J. Selhub, P. F. Jacques, P. W. Wilson, D. Rush, and I. H. Rosenberg, “Vitamin status and intake as primary determinants of homocysteinemia in an elderly population,” The Journal of the American Medical Association, vol. 270, no. 22, pp. 2693–2698, 1993. View at Publisher · View at Google Scholar
  24. C. Evereklioglu, H. Er, Y. Türköz, and M. Çekmen, “Serum levels of TNF-α, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Behçet's disease,” Mediators of Inflammation, vol. 11, no. 2, pp. 87–93, 2002. View at Publisher · View at Google Scholar · View at PubMed
  25. B. Wechsler, F. Davatchi, Y. Mizushima et al., “Criteria for diagnosis of Behçet's disease,” The Lancet, vol. 335, no. 8697, pp. 1078–1080, 1990. View at Google Scholar
  26. B. B. Bhakta, P. Brennan, T. E. James, M. A. Chamberlain, B. A. Noble, and A. J. Silman, “Behçet's disease: evaluation of a new instrument to measure clinical activity,” Rheumatology, vol. 38, no. 8, pp. 728–733, 1999. View at Publisher · View at Google Scholar
  27. G. Lawton, B. B. Bhakta, M. A. Chamberlain, and A. Tennant, “The Behçet's disease activity index,” Rheumatology, vol. 43, no. 1, pp. 73–78, 2004. View at Publisher · View at Google Scholar · View at PubMed
  28. C. Korkmaz, B. Bozan, M. Kosar, F. Sahin, and Z. Gülbas, “Is there an association of plasma homocysteine levels with vascular involvement in patients with Behçet's syndrome?,” Clinical and Experimental Rheumatology, vol. 20, no. 4, supplement 26, pp. S30–S34, 2002. View at Google Scholar
  29. J.-L. Mege, N. Dilsen, V. Sanguedolce et al., “Over production of monocyte derived tumor necrosis factor α, interleukin (IL) 6, IL-8 and increased neutrophil superoxide generation in Behçet's disease. A comparative study with familial Mediterranean fever and healthy subjects,” Journal of Rheumatology, vol. 20, no. 9, pp. 1544–1549, 1993. View at Google Scholar
  30. C. Evereklioglu, “Current concepts in the etiology and treatment of Behçet disease,” Survey of Ophthalmology, vol. 50, no. 4, pp. 297–350, 2005. View at Publisher · View at Google Scholar · View at PubMed
  31. M. Baggiolini, B. Dewald, and B. Moser, “Human chemokines: an update,” Annual Review of Immunology, vol. 15, pp. 675–705, 1997. View at Publisher · View at Google Scholar · View at PubMed
  32. M. Kobayashi, M. Ito, A. Nakagawa et al., “Neutrophil and endothelial cell activation in the vasa vasorum in vasculo-Behçet disease,” Histopathology, vol. 36, no. 4, pp. 362–371, 2000. View at Publisher · View at Google Scholar
  33. I. C. Haznedaroglu, O. Ozdemir, O. Ozcebe, S. V. Dundar, and S. Kirazli, “Circulating thrombomodulin as a clue of endothelial damage in Behçet's disease,” Thrombosis and Haemostasis, vol. 75, no. 6, pp. 974–975, 1996. View at Google Scholar
  34. I. C. Haznedaroglu, O. I. Özcebe, O. Özdemir, I. Çelik, S. V. Dündar, and Ş. Kirazli, “Impaired haemostatic kinetics and endothelial function in Behçet's disease,” Journal of Internal Medicine, vol. 240, no. 4, pp. 181–187, 1996. View at Publisher · View at Google Scholar
  35. T. Ohkuma, T. Minagawa, N. Takada, M. Ohno, H. Oda, and H. Ohashi, “C-reactive protein, lipoprotein(a), homocysteine, and male sex contribute to carotid atherosclerosis in peritoneal dialysis patients,” American Journal of Kidney Diseases, vol. 42, no. 2, pp. 355–361, 2003. View at Publisher · View at Google Scholar
  36. P. Bogdanski, D. Pupek-Musialik, J. Dytfeld, M. Lacinski, A. Jablecka, and H. Jakubowski, “Plasma homocysteine is a determinant of tissue necrosis factor-α in hypertensive patients,” Biomedicine and Pharmacotherapy, vol. 62, no. 6, pp. 360–365, 2008. View at Publisher · View at Google Scholar · View at PubMed
  37. A. M. Gori, A. M. Corsi, S. Fedi et al., “A proinflammatory state is associated with hyperhomocysteinemia in the elderly,” American Journal of Clinical Nutrition, vol. 82, no. 2, pp. 335–341, 2005. View at Google Scholar
  38. B. Widner, F. Leblhuber, B. Frick, A. Laich, E. Artner-Dworzak, and D. Fuchs, “Moderate hyperhomocysteinaemia and immune activation in Parkinson's disease,” Journal of Neural Transmission, vol. 109, no. 12, pp. 1445–1452, 2002. View at Publisher · View at Google Scholar · View at PubMed
  39. T. Koga, K. Claycombe, and M. Meydani, “Homocysteine increases monocyte and T-cell adhesion to human aortic endothelial cells,” Atherosclerosis, vol. 161, no. 2, pp. 365–374, 2002. View at Publisher · View at Google Scholar
  40. M. Li, J. Chen, Y.-S. Li, Y.-B. Feng, X. Gu, and C.-Z. Shi, “Folic acid reduces adhesion molecules VCAM-1 expession in aortic of rats with hyperhomocysteinemia,” International Journal of Cardiology, vol. 106, no. 2, pp. 285–288, 2006. View at Publisher · View at Google Scholar · View at PubMed
  41. M. D. Silverman, R. J. Tumuluri, M. Davis, G. Lopez, J. T. Rosenbaum, and P. I. Lelkes, “Homocysteine upregulates vascular cell adhesion molecule-1 expression in cultured human aortic endothelial cells and enhances monocyte adhesion,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 22, no. 4, pp. 587–592, 2002. View at Publisher · View at Google Scholar
  42. M. A. Hofmann, E. Lalla, Y. Lu et al., “Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine model,” The Journal of Clinical Investigation, vol. 107, no. 6, pp. 675–683, 2001. View at Publisher · View at Google Scholar · View at PubMed
  43. N. Sattar, P. Crompton, L. Cherry, D. Kane, G. Lowe, and I. B. McInnes, “Effects of tumor necrosis factor blockade on cardiovascular risk factors in psoriatic arthritis: a double-blind, placebo-controlled study,” Arthritis & Rheumatism, vol. 56, no. 3, pp. 831–839, 2007. View at Publisher · View at Google Scholar · View at PubMed
  44. M. Ballow and R. Nelson, “Immunopharmacology: immunomodulation and immunotherapy,” The Journal of the American Medical Association, vol. 278, no. 22, pp. 2008–2017, 1997. View at Publisher · View at Google Scholar